Invention Grant
- Patent Title: Phospholipidation of imidazoquinolines and oxoadenines
-
Application No.: US16060142Application Date: 2016-12-12
-
Publication No.: US10774099B2Publication Date: 2020-09-15
- Inventor: Helene G. Bazin-Lee , Laura S. Bess , David A. Johnson
- Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/EP2016/080647 WO 20161212
- International Announcement: WO2017/102654 WO 20170622
- Main IPC: C07F9/10
- IPC: C07F9/10 ; C07F9/6558 ; C07F9/6561

Abstract:
The present invention relates to a process for phospholipidation of imidazoquinolines and oxoadenines. More particularly, the present invention relates to a high-yielding and scalable procedure for the phospholipidation of imidazoquinolines and oxoadenines which obviates the need to isolate unstable phosphoramidite intermediates. This process may be used for the phospholipidation of toll-like receptor 7 (TLR7)—active and toll-like receptor (TLR8)—active imidazoquinolines and oxoadenines.
Public/Granted literature
- US20180273560A1 PHOSPHOLIPIDATION OF IMIDAZOQUINOLINES AND OXOADENINES Public/Granted day:2018-09-27
Information query